New: companion diagnostics

Learn more
About us

Finding innovative

OMICS solutions

 

OHMX.bio operates as a premier Study Design Company (CRO), specializing in cutting-edge -omics technologies for extensive investigations, covering Discovery and (pre)clinical studies. Our tailored project management encompasses sample preparation, advanced data analysis, and sophisticated reporting across transcriptomics, translatomics, proteomics, and (epi)genetics.

 

 

Established in 2019 in Ghent, Belgium, as a spin-off from Ghent University, we tap into academic expertise in high-throughput analysis methods. Collaborative projects at OHMX.bio engage a skilled team of wet-lab scientists, bioinformaticians, and specialized experts, ensuring the delivery of optimal solutions.

 

 

Distinguished by continual innovation, we seamlessly integrate novel methodologies. OHMX.bio meets the growing demand for specialized technologies in measuring diverse -omics levels and intricate modifications, including DNA/RNA epigenetics and post-translational modifications, all while maintaining a steadfast commitment to advancing biological research frontiers.

Our team

Our team

Gerben Menschaert, Prof

CSO & Co-founder

Prof. Gerben Menschaert is the CSO and co-founder of OHMX.bio. He is an expert in high-throughput technologies (sequencing and mass spectrometry) and bioinformatics. After working for several years in both pharmaceutical and biotech companies (Janssen Pharmaceutica & deVGen) he built an academic career (Belgium, US, Australia). As CSO, he steers the OHMX.bio team.

Joannes van Cann, PhD

BD and Strategy Manager

Joannes van Cann (PhD) has an accomplished background in both science and business. His scientific career has stretched Europe, and he has supported Global Clinical Trials, while also pursuing an MBA at a world-renowned business school. His mission is to grow OHMX.bio through business development and by focusing on the company’s strategy.

Hendrik Van de Voorde

COO

Hendrik Van de Voorde is the operations manager at OHMX.bio. He has over 10 years of experience working in medical genetics with specific expertise in biomarker discovery and the implementation of novel epigentic technology. At OHMX.bio he is responsible for operations and oversees the design and execution of our full range of services.

Steven Verbruggen, PhD

Senior Bioinformatician

Dr. Steven Verbruggen is a bioscience engineer specialized in bioinformatics for high-throughput technologies (sequencing and mass spectrometry). In his Ph.D, he focused on the development of bioinformatic tools for multi-omic research. As a senior bioinformatician, he is responsible for all data science solutions within OHMX.bio.

Karolien De Kimpe

R&D scientist & QMS manager

Karolien De Kimpe is experienced in Human genetics, next generation sequencing and has a growing experience in third-generation sequencing. At OHMX.bio she manages wet lab projects and is responsible for implementing and maintaining the Information Security Management System (ISO2700) and Quality Management System (ISO 9001).

Anna Matsaroki

R&D scientist & project manager

Anna Matsaroki is the R&D scientist and Project leader at OHMX.bio. She is highly experienced in sequencing services with a main focus on epigenomics and transcriptomics. As a project manager, she is responsible for the project design and the wet lab procedures.

Arne Godderis

Junior bioinformatician

Arne Godderis is a junior bioinformatician at OHMX.bio. He has a keen interest in long-read sequencing. At OHMX.bio he is responsible for dry lab projects and implementing new bioinformatics tools.

Iuliana Vintea

Doctoral Researcher

Iuliana is a bioscience engineer specialized in cell and gene technology. Her focus now is on cancer research where she aims to develop a clinical diagnostic test to predict ferroptosis sensitivity based on Oxford Nanopore Sequencing.

Daan Inghelram

Marketeer (consulting)

Advisors

Advisors

Wim Van Criekinge, Prof

Scientific advisor

Prof. Wim Van Criekinge, together with Jan, is a co-founder of the Novalis Biotech Incubation. He is a tenured professor at the University of Gent with an interest in the use of machine learning in computational biology and bioinformatics.

Jan Van den Berghe

Business advisor

Jan Van den Berghe is a serial entrepreneur in the biotech industry, co-founding the Novalis biotech incubation together with Wim. He has co-founded and served as director for several successful biotech startups that have been acquired by leading healthcare and life science companies.

Katrien Vanhonacker, MBA

BD & Sales advisor

Katrien Vanonacker (MBA) recieved a master in biotech. She spent 15 years preferring techno-commercial roles in corporate companies such as European key account manager (QIAGEN), European field account specialist and EMEA marketing manager (Thermo Fisher).

Success stories

Success stories

First story

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nunc eu risus vel lorem aliquam pulvinar. Cras a purus diam. Nam ornare magna nec neque ullamcorper elementum faucibus in nisi. Suspendisse quis semper augue.

Second story

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nunc eu risus vel lorem aliquam pulvinar. Cras a purus diam. Nam ornare magna nec neque ullamcorper elementum faucibus in nisi. Suspendisse quis semper augue.

Third story

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nunc eu risus vel lorem aliquam pulvinar. Cras a purus diam. Nam ornare magna nec neque ullamcorper elementum faucibus in nisi. Suspendisse quis semper augue.

Partners
Partners
Find us

Find us
Work with us

Work with us

Business Developer

Research Scientist

Apply spontaneously